Plasminogen activation by invasive human pathogens

Thrombosis and Haemostasis

Volumn 77, Issue 1, 1997, Pages 1-10

  Boyle, Michael D P ^a   Lottenberg, Richard ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; MATRIX METALLOPROTEINASE; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; SERINE PROTEINASE INHIBITOR;

BACTERIAL INFECTION; BORRELIA BURGDORFERI; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PATHOGENESIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; YERSINIA PESTIS;

EID: 0031042682     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1655727     Document Type: Review

References (135)

1. Collen D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost 1980; 43: 77-89.
2. Plow E F, Herren T, Redlitz A, Miles L A, Hoover-Plow J L. The cell biology of the plasminogen system. FASEB J 1995; 9: 939-45.
3. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991; 88: 1067-72.
4. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Gabiga S. Effect of plasminogen activator (urokinase), plasmin and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981; 41: 4629-36.
5. Mullins DE, Rohrlich ST. The role of proteases in cellular invasiveness. Biochem Biophys Acta 1983; 695; 177-214.
6. Pöllänen J, Stephens RW, Vaheri A. Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 1991; 57: 273-328.
7. Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 139-266.
8. Tryggvason K, Höyhtyä M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987; 907: 191-217.
9. McNeill H, Jensen P J. A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration. Cell Regulation 1990; 1: 843-52.
10. Strickland S, Reich E, Sherman MI. Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm. Cell 1976; 9: 231-40.
11. Lottenberg R, Minning-Wenz D, Boyle MDP. Capturing host plasminogen: a common mechanism for invasive pathogens? Trends in Micro 1994; 2: 20-4.
12. Eberhard T, Ullberg, M, Sjöström, I, Kronvall G, Wiman B. Enhancement of t-PA-mediated plasminogen activation by bacterial surface receptors. Fibrinolysis 1995; 9: 65-70.
13. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plague. Science 1992; 258: 1004-7.
14. Ben-Nasr A, Wistedt A, Ringdahl U, Sjöbring U. Streptokinase activates plasminogen bound to human group C and G streptococci through M-like proteins. Eur J Biochem 1994; 222: 267-76.
15. Coleman JL, Sellati TJ, Testa JE, Kew RR, Furie MB, Benach JL. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers. Infect Immun 1995; 63: 2478-84.
16. Sjöbring U, Pohl G, Olsén A. Plasminogen, absorbed by Escherichia coli expressing curli or by Salmonella enteritidis expressing thin aggregative fimbriae, can be activated by simultaneously captured tissue-type plasminogen activator (t-PA). Mol Microbiol 1994; 14: 443-52.
17. Lähteenmäki K, Virkola R, Pouttu R, Kuusela P, Kukkonen M, Korhonen TK. Bacterial plasminogen receptors: In vitro evidence for a role in degradation of the mammalian extracellular matrix. Infect Immun 1995; 63: 3659-64.
18. Wallen, P, Wiman B. Characterization of human plasminogen: II Separation and partial characterization of different molecular forms of human plasminogen. Biochim Biophys Acta 1972; 257: 122-34.
19. Lijnen HR, Collen D. Congenital and acquired deficiencies of components of the fibrinolytic system and their relation to bleeding or thrombosis. Fibrinolysis 1989; 3: 67-77.
20. Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow EF, Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995; 92: 2585-93.
21. Bachmann F, Kruithof IE. Tissue plasminogen activator: chemical and physiological aspects. Semin Thromb Hemost 1984; 10: 6-17.
22. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan R. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-24.
23. Robbins KC. Dysplasminogenemias. Progress in Cardiovascular Disease 1992; 34: 295-308.
24. Kruithof EK. Plasminogen activator inhibitors - a review. Enzyme 1988; 40: 113-21.
25. Kruithof EK, Baker MS, Bunn CL. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 1995; 86: 4007-24.
26. Erickson LA, Fici GJ, Lund JE, Boyle TP, Polites HG, Marotti KR. Development of venous occlusions in mice transgenic for the plasminogen activator inibitor-1 gene. Nature 1990; 346: 74-6.
27. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis and thrombolysis. J Clin Invest 1993; 92: 2756-60.
28. Fay WP, Shapiro AD, Shih JL, Schleef RR, Ginsburg D. Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation. New Eng J Med 1992; 327: 1729-33.
29. Vassalli J-D. The urokinase receptor. Fibrinolysis 1994; 8 Suppl. 1: 172-81.
30. Salyers AA, Whitt DD. Bacterial pathogenesis. A molecular approach. ASM Press 1994.
31. Finlay BB, Falkow S. Common themes in microbial pathogenicity. Microbiol Rev 1989; 53: 210-30.
32. Findlay BB. Molecular genetic approaches to understanding bacterial pathogenesis. In: Molecular biology of bacterial infections: current status and future perspectives. Normaeche CE, Penn CW, Smith CJ (eds). Cambridge University Press, New York 1992; pp 35-45.
33. Donnenberg MS, Donohue-Rolfe A, Keusch GT. Epithelial cell invasion: an overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor. J Infect Dis 1989; 160: 452-9.
34. Clerc P, Sansonetti PJ. Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect Immun 1987; 55: 2681-8.
35. Isberg RR. Discrimination between intracellular uptake and surface adhesion of bacterial pathogens. Science 1991; 252: 934-8.
36. Straley SC, Skrzypek E, Plano GV, Bliska JB. Yops of Yersinia spp. pathogenic for humans. Infect Immun 1993; 61: 3105-10.
37. Galan JE, Pace J, Hayman MJ. Involvement of the epidermal growth factor receptor in the invasion of cultured mammalian cells by Salmonella typhimurium. Nature 1992; 357: 588-9.
38. Ginocchio C, Pace J, Galan JE. Identification and molecular characterization of a Salmonella typhimurium gene involved in triggering the internalization of salmonellae into cultured epithelial cells. Proc Natl Acad Sci USA 1992; 89: 5976-80.
39. Finlay BB, Falkow S. Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. Biochimie 1988; 70: 1089-99.
40. Cossart P, Boquet P, Normark S, Rappuoli R. Cellular microbiology emerging. Science 1996; 271: 315-6.
41. Moulder JW. Comparative biology of intracellular parasitism. Microbiol Rev 1985; 49: 298-337.
42. Finlay BB, Ruschkowski S, Dedhar S. Cytoskeletal rearrangements accompanying Salmonella entry into epithelial cells. J Cell Sci 1991; 99: 283-96.
43. Mekalanos JJ. Environment signals controlling expression of virulence gene determinants in bacteria. J Bact 1992; 174: 1-7.
44. McIver KS, Heath AS, Scott JR. Regulation of virulence by environmental signals in group A streptococci: Influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription. Infect Immun 1995; 63: 4540-2.
45. Okada N, Geist RT, Caparon MG. Positive transcriptional control of mry regulates virulence in the group A streptococcus. Mol Microbiol 1993; 7: 893-903.
46. Murray PJ, Young RA. Stress and immunological recognition in host-pathogen interactions. J Bacteriol 1992; 174: 4193-6.
47. Clark V. Environmental modulation of gene expression in gram negative pathogens. In: The bacteria. Vol XI. Iglewohr BH, Clark VL, eds. San Diego: Academic Press 1990; pp 111-35.
48. Miller JF, Mekalanos JJ, Falkow S. Coordinate regulation and sensory transduction in the control of bacteria virulence. Science 1989; 243: 916-22.
49. Mahan MJ, Slauch JM, Mekalanos JJ. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 1993; 259: 680-8.
50. Raeder R, Boyle MDP. Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J Infect Dis 1996; 173: 888-95.
51. Armstrong D. Treatment of opportunistic fungal infections. Clin Infect Dis 1993; 16: 1-7.
52. Gradon JD, Timpone JG, Schnittman SM. Emergence of unusual opportunistic pathogens in AIDS: a review. Clinic Infect Dis 1992; 1: 134-57.
53. Lehrer RI, Ganz T, Selsted ME, Babior BM, Curnutte JT. Neutrophils and host defense. Annals Internal Medicine 1988; 109: 127-42.
54. Frank MM. Complement in the pathophysiology of human disease. New Eng J Med 1987; 316: 1525-30.
55. Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 1988; 10: S274-6.
56. Boyle MDP. Analysis of host-pathogen interactions. Implications for pathogenesis. J Micro Meth 1993; 18: 164-5.
57. Lottenberg R, Broder CC, Boyle MDP. Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun 1987; 55: 1914-28.
58. Fuchs H, Wallich R, Simon MM, Kramer MD. The outer surface protein A of the spirochete Borrelia burgdorferi is a plasminogen receptor. Proc Natl Acad Sci USA 1994; 91: 12594-8.
59. Lahteenmaki K, Westerlund B, Kuusela P, Korhonen TK. Immobilization of plasminogen on Escherichia coli flagella. FEMS Microbiol Lett 1993; 106: 309-14.
60. Ullberg M, Kronvall G, Karlsson I, Wiman B. Receptors for human plasminogen on gram-negative bacteria. Infect Immun 1990; 58: 21-5.
61. Rigner M, Valkonen KH, Wadstrom T. Binding of vitronectin and plasminogen to Helicobacter pylori. FEMS Immunol. Med Microbiol 1994; 9: 29-34.
62. Ullberg M, Kuusela P, Kristiansen B. Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasmin. J Infect Dis 1992; 166: 1329-34.
63. Tarshis M, Morag B, Mayer M. Mycoplasma cells stimulate in vitro activation of plasminogen by purified tissue-type plasminogen activator. FEMS Microbiology Letters 1993; 106: 201-4.
64. Kuusela P, Saksela O. Binding and activation of plasminogen at the surface of Staphylococcus aureus, increase in affinity after conversion to the Lys form of the ligand. Eur J Biochem 1990; 193: 759-65.
65. Parkkinen J, Korhonen TK. Binding of plasminogen to Escherichia coli adhesion proteins. FEBS Lett 1989; 250: 437-40.
66. Kuusela P, Ullberg M, Saksela O, Kronvall G. Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptococci. Infect Immun 1992; 60: 196-201.
67. Ullberg M, Kronvall G, Wiman B. New receptor for human plasminogen on Gram-positive cocci. APMIS 1989; 97: 996-1002.
68. Boyle MDP, Wang H, Lottenberg R, Ullberg M, Kuusela P, Kronvall G. Evidence for heterogeneity of binding of plasmin(ogen) forms to group A streptococci. 1995, 95th ASM Annual General Meeting, Washington DC.
69. Broder CC, Lottenberg R, Boyle MDP. Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci. Infect Immun 1989; 57: 2597-605.
70. Berge A, Sjobring U. PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J Biol Chem 1993; 34: 25417-24.
71. Wistedt AC, Ringdahl U, Müller-Esterl W, Sjöbring U. Identification of a plasminogen-binding motif in PAM, a bacterial surface protein. Mol Microbiol 1995; 18: 569-78.
72. Wang H, Lottenberg R, Boyle MD. Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis 1994; 169: 143-9.
73. Broder CC, Lottenberg R, von Mering GO, Johnston KH, Boyle MDP. Isolation of a prokaryotic plasmin receptor: Relationship to a plasminogen activator produced by the same micro-organisms. J Biol Chem 1991; 266: 4922-8.
74. Lottenberg R, Broder CC, Boyle MDP, Kain SJ, Schroeder BL, Curtiss III R. Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol 1992; 174: 5204-10.
75. Winram SB, Lottenberg R. The plasmin binding protein Plr of group A streptococci is identified as glyceraldehyde-3-phosphate dehydrogenase. Microbiol 1996; 142: 2311-20.
76. Des Jardin LE, Boyle MDP, Lottenberg R. Group A streptococci bind human plasmin but not other structurally related proteins. Thrombosis Research 1989; 55: 187-93.
77. Broeseker TA, Boyle MDP, Lottenberg R. Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus. Microb Pathog 1988; 5: 19-27.
78. Brubaker RR, Beesley ED, Surgalla MJ. Role of pesticin 1 and iron in experimental plague. Science 1965; 149: 4224.
79. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plaque. Science 1992; 258: 1004-7.
80. Sodeinde OA, Goguen JD. Genetic analysis of the 9.5-kilobase virulence plasmid of Yersinia pestis. Infect Immun 1988; 56: 2743-8.
81. Sodeinde OA, Sample A, Brubaker RR, Goguen JD. Plasminogen activator/coagulase gene in Yersinia pestis is responsible for degradation of plasmid-encoded outer membrane proteins. Infect Immun 1988; 56: 2749-52.
82. McDonough KA, Barnes AM, Quan TJ, Montenieri J, Falkow S. Mutation in the pla gene of Yersinia pestis alters the course of the plague bacillus-flea (Siphonaptera: Ceratophyllidae) interaction. J Med Entomol 1993; 30: 772-80.
83. Kienle Z, Emödy L, Svanborg C, O'Toole PW. Adhesive properties conferred by the plasminogen activator of Yersinia pestis. J Gen Microbiol 1992; 138: 1679-87.
84. Bliska JB. Yops of the pathogenic Yersinia spp. In: Molecular Genetics of Bacterial Pathogenesis. Miller VL, Kaper JB, Portnoy DA, Isberg RR, eds. ASM Press 1994; pp 365-81.
85. Reddy KNN, Markus G. Mechanism of activation of human plasminogen by streptokinase. J Biol Chem 1972; 247: 1683-91.
86. Castellino FJ, Sodetz JM, Brockway WJ, Sefring Jr GE. Streptokinase. Methods Enzymol 1976; 45: 244-57.
87. Cederholm-Williams SA, Decock F, Linjen HR, Collen D. Kinetics of the reactions between streptokinase, plasmin and alpha-2-antiplasmin. Eur J Biochem 1979; 100: 125-32.
88. Lynch M, Littler WA, Pentecost BL, Stockley RA. Immunoglobulin response to intravenous streptokinase in acute myocardial infarction. Br Heart J 1991; 66: 139-42.
89. Huang TT, Malke H, Ferretti JJ. Heterogeneity of the streptokinase gene in group A streptococci. Infect Immun 1989; 57: 502-6.
90. Malke H. Polymorphism of the SK gene: Implications for the pathogenesis of post-streptococcal glomerulonephritis. International Journal Medical Microbiology, Virology, Parasitology, Infectious Disease 1993; 278: 246-57.
91. Johnston KH, Chaiban JE, Wheeler RC. Analysis of the variable domain of the SK gene from streptococci associated with post-streptococcal glomerulonephritis. NBZ Bakt Suppl 1992; 22: 339-42.
92. Caballero A, Johnston KH, Lottenberg R. Cloning, expression and sequence analysis of streptokinases from Streptococcus equisimilis which preferentially activate equine and porcine plasminogens 1995, 95th General Meeting, ASM.
93. McCoy HE, Broder CC, Lottenberg R. Streptokinases produced by pathogenic group C streptococci demonstrate species-specific plasminogen activation. J Infect Dis 1991; 164: 515-21.
94. Wohl RC, Sinio L, Summaria L, Robbins KC. Comparative activation kinetics of mammalian plasminogens. Biochim Biophys Acta 1983; 745: 20-31.
95. Marcum JA, Kline DL. Species specificity of streptokinase. Comp Biochem Physiol 1983; 75: 389-94.
96. Lottenberg R, Des Jardin LE, Wang H, Boyle MDP. Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity. J Infect Dis 1992; 166: 436-40.
97. Wang H, Lottenberg R, Boyle MDP. A role for fibrinogen in the strepto-kinase-dependent acquisition of plasmin(ogen) by group A streptococci. Journal of Infectious Diseases 1995; 171 (1): 85-92.
98. Wang H, Lottenberg R, Boyle MDP. Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen. Microbial Pathogenesis 1995; 18: 153-66.
99. Malke H, Mechold U, Gase K, Gerlach D. Inactivation of the streptokinase gene prevents Streptococcus equisimilis H46A from acquiring cell-associated plasmin activity in the presence of plasminogen. FEMS Microbiol Let 1994; 116: 107-12.
100. Raeder R, Christner R, Podbielski A, Boyle MDP. Role for a fibrinogen-binding M protein supergene family product in the acquisition by group A streptococci of a surface streptokinase dependent enzymatic activity. 1995; 95th General Meeting ASM.
101. Ryc M, Beachey EH, Whitnack E. Ultrastructural localization of the fibrinogen-binding domain of streptococcal M protein. Infect Immun 1989; 57: 2397-404.
102. Poirier TP, Kehoe MA, Whitnack E, Dockter ME, Beachey EH. Fibrinogen binding and resistance to phagocytosis of Streptococcus sanguis expressing cloned M protein of Streptococcus pyogenes. Infect Immun 1989; 57: 29-35.
103. Boyle MDP, Weber-Heynemann J, Raeder R, Podbielski A. Characterization of a gene coding for a type IIo bacterial IgG-binding protein. Molec Immunol 1995; 32: 669-78.
104. Courtney HS, Li Y, Dale JB, Hasty DL. Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci. Infect Immun 1994; 62: 3937-46.
105. Schmidt KH, Köhler W. Interaction of streptococcal cell wall components with fibrinogen. I. Adsorption of fibrinogen by immobilized T-proteins of Streptococcus pyogenes. Immunobiol 1981; 158: 330-7.
106. Bisno A, Stevens DL. Streptococcal infections of skin and soft tissues. New Eng J of Med 1996; 2334: 240-5.
107. Bisno A. Group A streptococcal infections and acute rheumatic fever. Med Prog 1991; 325: 783-93.
108. Fischetti VA. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 1989; 2: 285-314.
109. Li Z, Boyle MDP. Role of cell associated plasmin-like enzymatic activity in providing group A streptococci with an invasive phenotype in a mouse skin infection model (in preparation).
110. Verstraete M, Lijnen HR, Collen D. Thrombolytic agents in development. Drugs 1995; 50: 29-42.
111. Christner R, Boyle MDP. Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci. J Infect Dis 1996; 173: 104-12.
112. Hu LT, Pendes G, Noring R, Klempner MS. Binding of human plasminogen to Borrelia burgdorferi. Infect Immun 1995; 63: 3491-6.
113. Klempner MA, Noring R, Epstein M, McCloud B, Hu R, Limentani SA, Rogers RA. Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 1995; 171: 1258-65.
114. Liu JN, Gurewich V. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin. J Clin Invest 1991; 88: 2012-7.
115. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: Identification of α-enolase as a candidate plasminogen receptor. Biochem 1991; 30: 1682-91.
116. Lopez-Alemany R, Correc P, Camoin L, Burtin P. Purification of the plasmin receptor from human carcinoma cells and comparison to alpha-enolase. Thromb Res 1994; 75: 371-81.
117. Nakajima K, Hamanoue M, Takemoto N, Hattori T, Kato K, Kohsaka S. Plasminogen binds specifically to alpha-enolase on rat neuronal plasma membrane. J Neurochem 1994; 222: 267-76.
118. Winram SB, Richardson LC, Lottenberg R. Mutational analysis of a plasmin receptor protein expressed by group A streptococci. In: Genetics of streptococci, enterococci and lactococci. Ferretti JJ, Gilmore MS, Klaenhammer TR, Brown F, eds. Dev Biol Stand Basel, Karger, 1995, vol 85, pp 199-202.
119. Pancholi V, Fischetti VA. A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate dehydrogenase with multiple binding activity. J Exp Med 1992; 176: 415-26.
120. Eichenbaum Z, Green BD, Scott JR. Iron starvation causes release from the group A streptococcus of the ADP-Ribosylating protein called plasmin receptor or surface glyceraldehyde-3-Phosphate-Dehydrogenase. Infect Immun 1996; 64: 1956-60.
121. Miles LA, Ginsberg MH, White JG, Plow EF. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001-9.
122. Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986; 103: 2411-20.
123. Blasi F, Verde P. Urokinase-dependent cells surface proteolysis and cancer. Cancer Biol 1990; 1: 117-26.
124. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. J Biol Chem 1994; 33: 21191-7.
125. Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator. J Biol Chem 1994; 269: 21198-203.
126. Blasi F. Surface receptors for urokinase plasminogen activator. Fibrinolysis 1888; 2: 73-84.
127. Ossowski L. Invasion of connective tissue by human carcinoma cell lines: Requirement for urokinase, urokinase receptor and interstitial collagenase. Cancer Res 1992; 52: 6754-60.
128. Gyetko MR, Todd RF III, Wilkinson CC, Sitrin RG. The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin Invest 1994; 93: 1380-7.
129. Pepper MS, Sappino A-P, Stöcklin R, Montesano R, Orci L, Vassali J-D. Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 1993; 122: 673-84.
130. Del Rosso M, Anichini E, Pedersen N, Bias F, Fibbi G, Pucci M, Ruggiero M. Urokinase-urokinase receptor interaction: Non-mitogenic signal transduction in human epidermal cells. Biochem Biophys Res Commun 1993; 190: 347-52.
131. Chung CY, Erickson HP. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol 1994; 126: 539-48.
132. Caparon M, Scott JR. Genetic manipulation of pathogenic streptococci. Meth Enz 1991; 204: 556-86.
133. Podbielski A, Flosdorff A, Weber-Heynemann J. The group A streptococcal vir 49 gene controls expression of four structural vir regulon genes. Infect Immun 1995; 63: 9-20.
134. Gulig P. Use of isogenic mutants to study bacterial virulence factors. J Microbiol Meth 1993; 18: 275-87.
135. Ryffel B. Cytokine knock-out mice. Possible application in toxicological research. Toxicology 1995; 105: 69-80.